Non-Obese Diabetic SCID Mouse
Featured In: Cancer | Transgenic
Wednesday, January 12, 2005
Recent studies indicate that the new NOD (non-obese diabetic) scid Spontaneous Mutant Model (NOD scid mouse), is a useful model for both cancer research and research in several immune-related disorders. The scid mutation has been transferred onto a diabetes-susceptible non-obese diabetic (NOD) background making it an excellent model for studies in increased tumor incidence, especially for lymphomas and thymic tumors. There is minimal immune “leakiness” on the NOD background. Characteristics of the NOD scid model include a lack of T and B cell development. The multiple defects in immunity unique to this model provide an excellent system for reconstitution with human hematopoietic cells, while also making it a useful model for HIV-1 research and gene therapy. The NOD scid mouse model was originally received at M&B A/S in 1995. The scid mutation was transferred from the C.B-17 congenic background onto the diabetes-susceptible non-obese diabetic background.